drugset / Trial / NCT04071821

Relative Bioavailability Study to Evaluate Cetirizine HCl Gummy 10 mg and Cetirizine HCl Oral Tablets 10 mg

NCT04071821

Phase 1 Unknown 30 enrolled Seattle Gummy Company
RandomizedCrossoverOpen-labelOther

Summary

A Randomized, Open-Label, Single-Dose, Five-Period Crossover, Relative Bioavailability Study to Evaluate Cetirizine HCl Gummy 10 mg and Cetirizine HCl Oral Tablets 10 mg Administered in Healthy Adult Male and Female Subjects

Timeline

Start
2025-05-01
Primary completion
2025-07-15
Completion
2025-09-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cetirizine Other / unclassified 10 mg Oral

Indications